4//SEC Filing
KANE MATTHEW R. 4
Accession 0001209191-21-039278
CIK 0001357874other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 6:37 PM ET
Size
8.7 KB
Accession
0001209191-21-039278
Insider Transaction Report
Form 4
KANE MATTHEW R.
DirectorPresident and CEO10% Owner
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-06-07+1,312→ 1,312 total(indirect: By Spouse)Exercise: $11.34Exp: 2031-06-06→ Common Stock (1,312 underlying) - Award
Restricted Stock Units
2021-06-07+763→ 763 total(indirect: By Spouse)→ Common Stock (763 underlying)
Footnotes (4)
- [F1]The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date.
- [F2]Employee Stock Option is held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F3]The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
- [F4]The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001769887
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 6:37 PM ET
- Size
- 8.7 KB